英文描述:Canakinumab (ACZ885) is a recombinant human anti-IL-1β monoclonal antibody. Canakinumab shows IC50 values of 43.6 and 40.8 pM for human and marmoset IL-1β, respectively. The mode of action of canakinumab is based on the neutralization of IL-1β signaling, resulting in suppression of inflammation related to disorders of autoimmune origin.Purity:>95% (SDS-PAGE&SEC)Endotoxin Level:< 1.0EU/mg.
Specifications and Purity: ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
- UPC:
- 51111611
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab170512-10mg
- CAS:
- 914613-48-2
- Product Size:
- 10mg
akash.verma@cenmed.com
(732) 447-1115





